View of Prospects of using the sodium-dependent glucose transporter type 2 inhibitor empagliflosin in patients with heart failure

Return to Article Details Prospects of using the sodium-dependent glucose transporter type 2 inhibitor empagliflosin in patients with heart failure Download Download PDF